| |
| |
|
| Insider
Information: |
Dean Lloyd H |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
98,751 |
|
|
Indirect Shares
|
75,359 |
|
|
| Direct
Value |
$1,435,999 |
|
|
|
Indirect Value
|
$2,129,103 |
|
|
| Total
Shares |
174,110 |
|
|
| Total
Value |
$3,565,102 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Wells Fargo & Co |
WFC |
Director |
2018-03-01 |
13,008 |
2018-03-01 |
35,359 |
Premium* |
|
|
Plus Therapeutics Inc |
PSTV |
Director |
2014-05-19 |
51,059 |
2014-05-19 |
40,000 |
Premium* |
|
|
Navigant Consulting Inc |
NCI |
Director |
2016-05-17 |
22,983 |
2014-05-15 |
0 |
Premium* |
|
|
McDonalds Corp |
MCD |
Director |
2019-03-31 |
0 |
2017-09-30 |
0 |
Premium* |
|
|
Progyny, Inc. |
PGNY |
Director |
2024-05-23 |
11,701 |
2022-10-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| WFC |
Wells Fargo & Co |
Director |
– • – |
2005-06-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
500 |
|
- |
|
| WFC |
Wells Fargo & Co |
Director |
– • – |
2008-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,343 |
2,343 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2013-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,100 |
6,100 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2014-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,550 |
10,550 |
0 |
- |
|
| NCI |
Navigant Consulting Inc |
Director |
– • – |
2014-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,941 |
6,941 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2014-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,409 |
13,959 |
0 |
- |
|
| NCI |
Navigant Consulting Inc |
Director |
– • – |
2015-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
8,427 |
15,368 |
0 |
- |
|
| WFC |
Wells Fargo & Co |
Director |
• • – |
2016-03-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,210 |
39,598 |
0 |
- |
|
| WFC |
Wells Fargo & Co |
Director |
• • – |
2016-03-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,210 |
3,332 |
0 |
- |
|
| NCI |
Navigant Consulting Inc |
Director |
– • – |
2016-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
7,615 |
22,983 |
0 |
- |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2022-10-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900 |
2,900 |
0 |
- |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,654 |
6,554 |
0 |
- |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2024-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
5,147 |
11,701 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2012-12-19 |
4 |
B |
$2.85 |
$71,250 |
I/I |
25,000 |
40,000 |
2.1 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2011-08-12 |
4 |
B |
$3.08 |
$23,082 |
I/I |
7,500 |
9,000 |
2.1 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2011-09-14 |
4 |
B |
$3.13 |
$18,890 |
I/I |
6,000 |
15,000 |
2.1 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2010-11-01 |
4 |
A |
$4.70 |
$98,700 |
D/D |
21,000 |
21,000 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2011-05-20 |
4 |
B |
$5.27 |
$7,907 |
I/I |
1,500 |
1,500 |
2.1 |
- |
|
| WFC |
Wells Fargo & Co |
Director |
• • – |
2013-11-01 |
4 |
OE |
$19.48 |
$240,188 |
D/D |
12,330 |
40,000 |
0 |
- |
|
| WFC |
Wells Fargo & Co |
Director |
– • – |
2010-03-01 |
4 |
OE |
$27.35 |
$376,664 |
D/D |
13,772 |
16,115 |
0 |
- |
|
| WFC |
Wells Fargo & Co |
Director |
• • – |
2015-04-23 |
4 |
OE |
$30.67 |
$192,056 |
D/D |
6,262 |
38,834 |
0 |
- |
|
| WFC |
Wells Fargo & Co |
Director |
– • – |
2012-03-01 |
4 |
OE |
$31.54 |
$122,186 |
D/D |
3,874 |
27,553 |
0 |
- |
|
| WFC |
Wells Fargo & Co |
Director |
– • – |
2011-03-01 |
4 |
OE |
$31.65 |
$232,564 |
D/D |
7,348 |
23,629 |
0 |
- |
|
| WFC |
Wells Fargo & Co |
Director |
• • – |
2016-03-01 |
4 |
OE |
$32.55 |
$420,514 |
D/D |
10,841 |
41,808 |
0 |
- |
|
| WFC |
Wells Fargo & Co |
Director |
• • – |
2017-04-18 |
4 |
OE |
$35.78 |
$264,557 |
D/D |
7,394 |
13,103 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
